Search results
KeyBanc Overweight on Parker-Hannifin stock after analyst day By Investing.com
Investing.com· 3 hours agoOn Friday, KeyBanc Capital Markets sustained its positive outlook on Parker-Hannifin Corporation...
KeyBanc maintains Workday stock at overweight, cites upcoming earnings By Investing.com
Investing.com· 4 hours agoOn Friday, KeyBanc Capital Markets maintained its Overweight rating on Workday (NASDAQ:WDAY) stock,...
Bharti Airtel: JPM raises to ‘overweight,’ sees stronger earnings
Investing.com· 2 days agoBharti Airtel: JPM raises to ‘overweight,’ sees stronger earnings
How Long Can I Stay on Ozempic For Weight Loss?
MediaFeed via AOL· 6 hours agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid answer to this question yet.
European equity selloff likely as US economic data weakens - BOA Securities By Investing.com
Investing.com· 2 hours agoEquity markets have surged to all-time highs, but with U.S. economic data starting to cool, Bank of...
JPMorgan maintains Ford stock overweight rating By Investing.com
Investing.com· 8 hours agoOn Friday, JPMorgan reaffirmed its Overweight rating and $15.00 price target on Ford Motor Company...
KeyBanc reiterates overweight on GoodRx, positive after inaugural Investor Day By Investing.com
Investing.com· 1 day agoOn Thursday, KeyBanc Capital Markets maintained its Overweight rating on shares of GoodRx Holdings...
Piper Sandler bullish on Stellantis stock, cites 'distinct' strategy By Investing.com
Investing.com· 4 hours agoOn Friday, Piper Sandler confirmed its Overweight rating on Stellantis NV (NYSE:NYSE:STLA) stock...
Netflix and Trade Desk stocks retain Overweight ratings, targets unchanged By Investing.com
Investing.com· 3 hours agoOn Friday, KeyBanc Capital Markets maintained its optimistic stance on both Netflix, Inc....
Piper Sandler maintains target on Aligos Therapeutics shares, says its a 'hidden gem' By...
Investing.com· 4 hours agoOn Friday, Piper Sandler reaffirmed its Overweight rating on Aligos Therapeutics Inc. (NASDAQ: ALGS)...